论文部分内容阅读
1有效成份莫米松糠酸酯（mometasonefuroate）2剂型鼻喷雾剂3开发与上市厂商（美）SoberingPlough公司，1997年在英国首次上市。4作用特点莫米松为合成皮质激素，结构与倍氯米松相似，其软膏剂和霜剂用于皮肤病治疗在美国已有近10年历史，近年莫米松糠酸酯鼻喷雾剂开发用于治疗
1 active ingredient mometasone furoate 2 Formulations Nasal Spray 3 Developed and Listed Manufacturer (US) SoberingPlough Inc., first listed in the UK in 1997. 4 Features Momesone is a synthetic corticosteroid and its structure is similar to that of beclomethasone. Its ointment and cream have been used in the treatment of dermatological diseases in the United States for nearly 10 years. In recent years, Mometasone furoate nasal spray has been developed for the treatment